Recommendation for the standardization of diagnosis and treatment of fatty liver disease
-
摘要:
<正>肝病至今仍是人类沉重的健康负担和五大死亡原因之一,肝病的发病率及其相关死亡亦无减轻迹象。究其原因主要为肥胖、糖尿病和酒精滥用相关脂肪性肝病的患病率增长迅猛,而其危害除影响肝脏外,还涉及糖尿病、动脉粥样硬化和肝外恶性肿瘤[1-2]。作为重要的慢性非传染性疾病,脂肪性肝病现已取代病毒性肝炎成为全球第一大肝病,对人类健康和社会发展构成
-
Key words:
- fatty liver /
- diagnosis /
- treatment /
- recommendation
-
[1]FAN JG.Epidemiology of alcoholic and non-alcoholic fatty liver disease in China[J].J Gastroenterol Hepatol, 2013, 28 (Suppl1) :11-17. [2]FAN JG, ZENG MD.Fatty liver disease[M].2nd Edition.Beijing:People's Medical Publishing House, 2013.范建高, 曾民德.脂肪性肝病[M].2版.北京:人民卫生出版社, 2013. [3] Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association, Chinese Medical Association.Guidelines for prevention and treatment of nonalcoholic liver disease (revised version 2010) [J].J Clin Hepatol, 2010, 26 (2) :120-124. (in Chinses) 中华医学会肝病学分会脂肪肝和酒精性肝病学组.非酒精性肝病诊疗指南 (2010年修订版) [J].临床肝胆病杂志, 2010, 26 (2) :120-124. [4] Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association, Chinese Medical Association.Guidelines for prevention and treatment of alcoholic liver disease (revised version 2010) [J].J Clin Hepatol, 2010, 26 (3) :229-232. (in Chinses) 中华医学会肝病学分会脂肪肝和酒精性肝病学组.酒精性肝病诊疗指南 (2010年修订版) [J].临床肝胆病杂志, 2010, 26 (3) :229-232. [5] Ministry of Health, People's Republic of China.Standards of construction for general hospitals (Construction standard 110-2008) , 2008.10.中华人民共和国卫生部.综合医院建设标准 (建标110-2008) 2008.10. [6]CHALASANI N, YOUNOSSI Z, LAVINE JE, et al.The diagnosis and management of non-alcoholic fatty liver disease:Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association[J].Hepatology, 2012, 55 (6) :2005-2023. [7]MOYER VA;U.S.Preventive Services Task Force.Screening for and management of obesity in adults:U.S.preventive services task force recommendation statement[J].Ann Intern Med, 2012, 157 (5) :373-378. [8]O’SHEA RS, DASARATHY S, MCCULLOUGH AJ, et al.Alcoholic liver disease[J].Hepatology, 2010, 51 (1) :307-322. [9]European Association for the Study of Liver.EASL clinical practical guidelines:management of alcoholic liver disease[J].J Hepatol, 2012, 57 (2) :399-420. [10]THOMA C, DAY CP, TRENELL MI.Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults:a systematic review[J].J Hepatol, 2012, 56 (1) :255-266. [11] Chinese Nutrition Society.Dietary guidelines for Chinese residents (2007) .中国营养学会专家委员会.中国居民膳食指南, 2007. [12]FAN JG, CAO HX.Role of diet and nutritional management in non-alcoholic fatty liver disease[J].J Gastroenterol Hepatol, 2013, 28 (Suppl 2) :41-47. [13] Chinese Medical Association Diabetes Branch.Guidelines on prevention and treatment of type 2 diabetes mellitus in China (2010) [J].Chin J Diabetes, 2012, 20 (1) :s1-s36. (in Chinese) 中华医学会糖尿病学分会.中国2型糖尿病防治指南 (2010年版) [J].中国糖尿病杂志, 2012, 20 (1) :s1-s36. [14]Joint Committee for Developing Chinese guidelines on Prevention and Treatment of Dyslipidemia in Adults.Chinese guidelines on prevention and treatment of dyslipidemia in adults[J].Chin J Cardiol, 2007, 35 (5) :390-419. (in Chinese) 中国成人血脂异常防治指南制订联合委员会.中国成人血脂异常防治指南[J].中华心血管病杂志, 2007, 35 (5) :390-419. [15]PARKER HM, JOHNSON NA, BURDON CA, et al.Omega-3supplementation and non-alcoholic fatty liver disease:a systematic review and meta-analysis[J].J Hepatol, 2012, 56 (4) :944-951. [16] Writing Group of 2010 Chinese Guidelines for the Management of Hypertension.2010 Chinese guidelines for the management of hypertension[J].Chin J Cardiol, 2011, 39 (7) :579-615.中国高血压防治指南修订委员会.中国高血压防治指南2010[J].中华心血管病杂志, 2011, 39 (7) :579-613. [17] NEWSOME PN, ALLISON ME, ANDREWS PA, et al.Guidelines for liver transplantation for patients with non-alcoholic steatohepatitis[J].Gut, 2012, 61 (4) :484-500.
本文二维码
计量
- 文章访问数: 3929
- HTML全文浏览量: 20
- PDF下载量: 1011
- 被引次数: 0